Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
The opioid crisis: Psychiatrists are well equipped to intervene
- Author:
- Sharon Worcester
Hypnosis, CBT, and other nonpharmacologic approaches to pain management that can help in the effort to reduce opioid use are among the tools...
News
Studies backing certain FDA approvals found lacking
- Author:
- Sharon Worcester
The quality of studies and data relied upon to support Food and Drug Administration–accelerated drug approvals and high-risk device modifications...
News
ALLOZITHRO trial: HSCT patients fared worse with azithromycin
- Author:
- Sharon Worcester
Early azithromycin in patients undergoing allogeneic hematopoietic stem cell transplant resulted in worse airflow decline–free survival than did...
News
FDA committee recommends approval of tofacitinib for PsA
- Author:
- Sharon Worcester
The FDA Arthritis Advisory Committee voted 10-1 in favor of approval of tofacitinib for psoriatic arthritis.
News
FDA committee rejects sirukumab approval on safety concerns
- Author:
- Sharon Worcester
Concerns over increased overall mortality in trials were most often cited.
News
Stopping statins after stroke may up recurrent stroke risk
- Author:
- Sharon Worcester
Nearly 20% of patients 3-6 months after a stroke, in a Taiwanese database, were not using statins. Read the findings of a large retrospective...
News
Novel device aims to make cervical cancer screening more accessible
- Author:
- Sharon Worcester
A novel vaginal inserter and mini colposcope currently in development at Duke University could have important implications for improving cervical...
News
Glioblastoma: Prognosis is poor, but new therapies are emerging
- Author:
- Sharon Worcester
Intensive, up-front treatment may help elderly patients with glioblastoma the most.
News
VA cohort study: Individualize SSI prophylaxis based on patient factors
- Author:
- Sharon Worcester
New combination against surgical site infections is associated with both benefits and harms.
News
M13-982 trial in del(17p) CLL: High, durable response rates to venetoclax
- Author:
- Sharon Worcester
Venetoclax monotherapy is well tolerated and associated with high and durable objective response rates in patients with del(17p) CLL, according to...
News
TKI dose de-escalation feasible in CML with stable MMR
- Author:
- Sharon Worcester
Tyrosine kinase inhibitor de-escalation is generally safe and may lead to symptom improvement in patients with chronic myeloid leukemia who...
News
Study: No increased mortality with ACA-prompted readmission declines
- Author:
- Sharon Worcester
Reductions in 30-day hospital readmission rates among Medicare fee-for-service beneficiaries are weakly but significantly correlated with...
News
Report: Opioid epidemic fight must increase substantially and immediately
- Author:
- Sharon Worcester
Efforts to prevent opioid overdose deaths should be increased substantially and immediately as a public health priority, according to an expert...
News
First-line obinutuzumab monotherapy in CLL linked to good response, reduced toxicity
- Author:
- Sharon Worcester
NEW YORK – Obinutuzumab monotherapy effective for the first-line treatment of chronic lymphocytic leukemia.
News
NF-kB inhibitor IT-901 shows promise in Richter syndrome
- Author:
- Sharon Worcester
In vitro analyses of primary leukemic cells and in vivo analyses in patient-derived xenograft models indicate NF-kB inhibition should be...